Temozolomide treatment alters mismatch repair and boosts mutational burden in tumor and blood of colorectal cancer patients

Overview of attention for article published in Cancer Discovery, May 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

So far, Altmetric has seen 110 X posts from 70 X users, with an upper bound of 253,768 followers.

RT @imsmd: .@Albert0Bardelli giving 5 examples of innovative ways to enhance immunosurveillance in patients with MMRd CRC #SCC2023HD: 👉🏻 re…

RT @imsmd: .@Albert0Bardelli giving 5 examples of innovative ways to enhance immunosurveillance in patients with MMRd CRC #SCC2023HD: 👉🏻 re…

RT @imsmd: .@Albert0Bardelli giving 5 examples of innovative ways to enhance immunosurveillance in patients with MMRd CRC #SCC2023HD: 👉🏻 re…

.@Albert0Bardelli giving 5 examples of innovative ways to enhance immunosurveillance in patients with MMRd CRC #SCC2023HD: 👉🏻 related paper https://t.co/0AcuLfmzZT

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 106 additional X posts.